http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0214299-A4

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1374dd16777534b65ad4422333245af8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
filingDate 1986-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72a6c59a286b4f72b2469003f5b0a526
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_167507e0b34f449f56f743239851c31c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_843c54d61b0b19db5d4c2fd08571e979
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a50cae9082c1dfb8c3a473a47e75da72
publicationDate 1988-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0214299-A4
titleOfInvention PREPARATION OF 5-FLUOR-2'-DEOXYURIDINE ESTERS FOR INTRAVENOUS ADMINISTRATION.
abstract A preparation of 5-fluoro-2'-deoxyuridine esters having markedly improved selective migration and accumulation properties into tumor tissue, which preparation comprises a highly fat-soluble derivative of 5-fluoro-2'-deoxyuridine with an antineoplastic effect and an oily base.
priorityDate 1985-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8500608-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0081386-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396423
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57196464
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5790
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503017

Total number of triples: 37.